{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:24:36Z","timestamp":1788805476358,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jacc.2019.02.074","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T13:58:59Z","timestamp":1558965539000},"page":"2705-2718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway"],"prefix":"10.1016","volume":"73","author":[{"given":"Keyvan","family":"Yousefi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila I.","family":"Irion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauro M.","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guerline","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Eisenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Sukkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk L.","family":"Granzier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Methawasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong I.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia S.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Kass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos E.","family":"Hatzistergos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"Hare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina A.","family":"Shehadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2019.02.074_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.021884","article-title":"Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap","volume":"134","author":"Shah","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.02.074_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/eurjhf\/hfq121","article-title":"Epidemiology and clinical course of heart failure with preserved ejection fraction","volume":"13","author":"Lam","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2019.02.074_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.02.074_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.02.074_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/jama.300.4.431","article-title":"Heart failure with preserved ejection fraction: treat now by treating comorbidities","volume":"300","author":"Shah","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.02.074_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","article-title":"Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart\u00a0Failure National Registry (ADHERE) Database","volume":"47","author":"Yancy","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.02.074_bib7","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.02.074_bib8","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jacc.2010.10.057","article-title":"Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction: a meta-analysis","volume":"57","author":"Holland","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.02.074_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.02.074_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCHEARTFAILURE.111.962654","article-title":"Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial","volume":"4","author":"Anand","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2019.02.074_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/ehv464","article-title":"Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction","volume":"37","author":"Solomon","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.02.074_bib12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ahj.2018.03.019","article-title":"The effect of Aliskiren on exercise capacity in older patients with heart failure and preserved ejection fraction: a randomized, placebo-controlled, double-blind trial","volume":"201","author":"Upadhya","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2019.02.074_bib13","first-page":"140","article-title":"Tolerability and feasibility of beta-blocker titration in HFpEF versus HFrEF: insights from the CIBIS-ELD Trial","volume":"4","author":"Edelmann","year":"2016","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2019.02.074_bib14","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1093\/eurheartj\/ehu254","article-title":"Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction","volume":"35","author":"Gori","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.02.074_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.445","article-title":"Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction","volume":"18","author":"Unger","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2019.02.074_bib16","doi-asserted-by":"crossref","first-page":"94818","DOI":"10.1172\/jci.insight.94818","article-title":"Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits","volume":"3","author":"Ding","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacc.2019.02.074_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cvr\/cvx016","article-title":"Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure","volume":"113","author":"Li","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2019.02.074_bib18","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/eurjhf\/hft112","article-title":"Diagnostic and prognostic value of osteopontin in patients with acute congestive heart failure","volume":"15","author":"Behnes","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2019.02.074_bib19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/01.HYP.33.2.663","article-title":"Myocardial osteopontin expression coincides with the development of heart failure","volume":"33","author":"Singh","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.02.074_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1388-9842(01)00237-9","article-title":"Increased myocardial expression of osteopontin in patients with advanced heart failure","volume":"4","author":"Philipp","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2019.02.074_bib21","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1161\/01.CIR.96.9.3063","article-title":"Myocardial osteopontin expression is associated with left ventricular hypertrophy","volume":"96","author":"Graf","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.02.074_bib22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1161\/CIRCHEARTFAILURE.110.960716","article-title":"Relation of peripheral collagen markers to death and hospitalisation in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen sub-study","volume":"4","author":"Krum","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2019.02.074_bib23","article-title":"Biomarker profiles in heart failure patients with preserved and reduced ejection fraction","volume":"6","author":"Tromp","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2019.02.074_bib24","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1681\/ASN.2006020165","article-title":"Loss of alpha3\/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3\u2212\/\u2212 Alport mice","volume":"17","author":"Kang","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2019.02.074_bib25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/clc.20932","article-title":"Usefulness of tissue doppler imaging-myocardial performance index in the evaluation of diastolic dysfunction and heart failure with preserved ejection fraction","volume":"34","author":"Kim","year":"2011","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2019.02.074_bib26","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/ejhf.154","article-title":"Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort","volume":"16","author":"Russo","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2019.02.074_bib27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","article-title":"Expert consensus document: mitochondrial function as a therapeutic target in heart failure","volume":"14","author":"Brown","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2019.02.074_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ejhf.239","article-title":"Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle","volume":"17","author":"Bowen","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2019.02.074_bib29","first-page":"312","article-title":"Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction","volume":"4","author":"Franssen","year":"2016","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2019.02.074_bib30","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/ndt\/gfx332","article-title":"Genetic background influences cardiac phenotype in murine chronic kidney disease","volume":"33","author":"Neuburg","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2019.02.074_bib31","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1152\/ajpendo.00596.2012","article-title":"FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy","volume":"304","author":"Touchberry","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.02.074_bib32","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/CIRCRESAHA.108.193326","article-title":"Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium","volume":"104","author":"Borb\u00e9ly","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2019.02.074_bib33","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/CIRCULATIONAHA.114.013215","article-title":"Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin","volume":"131","author":"Zile","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.02.074_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.004181","article-title":"Assessing contractile function when ejection fraction is normal: a case for strain imaging","volume":"8","author":"Biering-S\u00f8rensen","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2019.02.074_bib35","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1096\/fj.11-203091","article-title":"Improving the description of metabolic networks: the TCA cycle as example","volume":"26","author":"Stobbe","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.jacc.2019.02.074_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048770","article-title":"OGDHL is a Modifier of AKT-dependent signaling and NF-\u03baB function","volume":"7","author":"Sen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacc.2019.02.074_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuron.2016.11.038","article-title":"Loss of nardilysin, a mitochondrial co-chaperone for alpha-ketoglutarate dehydrogenase, promotes mTORC1 activation and neurodegeneration","volume":"93","author":"Yoon","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.jacc.2019.02.074_bib38","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1134\/S0026893315040044","article-title":"[Downregulation of OGDHL expression is associated with promoter hypermethylation in colorectal cancer]","volume":"49","author":"Fedorova","year":"2015","journal-title":"Mol Biol"},{"key":"10.1016\/j.jacc.2019.02.074_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biocel.2012.07.002","article-title":"Up-regulation of 2-oxoglutarate dehydrogenase as a stress response","volume":"45","author":"Graf","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jacc.2019.02.074_bib40","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ejhf.497","article-title":"Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation","volume":"18","author":"Ter Maaten","year":"2016","journal-title":"Eur J Heart Fail"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719346972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719346972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:21:33Z","timestamp":1760016093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109719346972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":40,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0735109719346972"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2019.02.074","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2019.02.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}